Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece.
Petridis A, Panagakis P, Moustou E, Vergou T, Kallidis P, Mandekou-Lefaki I, Chaidemenos G, Sotiriadis D, Alexopoulou G, Haratsis Y, Antoniou C. Petridis A, et al. Among authors: panagakis p. J Eur Acad Dermatol Venereol. 2018 May;32(5):768-775. doi: 10.1111/jdv.14802. J Eur Acad Dermatol Venereol. 2018. PMID: 29356149
Real-world data from a single Greek centre on the use of secukinumab in plaque psoriasis: effectiveness, safety, drug survival, and identification of patients that sustain optimal response.
Rompoti N, Sidiropoulou P, Panagakis P, Stratigos A, Papoutsaki M, Stefanaki E, Vavouli C, Politou M, Befon A, Kostakis P, Rigopoulos D, Nicolaidou E. Rompoti N, et al. Among authors: panagakis p. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1240-1247. doi: 10.1111/jdv.16202. Epub 2020 Feb 28. J Eur Acad Dermatol Venereol. 2020. PMID: 31953892
Treatment of nail psoriasis with calcipotriol/betamethasone dipropionate foam versus pulse dye laser: an unblinded, intra-patient, left-to-right prospective study.
Gregoriou S, Sidiropoulou P, Tsimpidakis A, Rompoti N, Tsironi T, Panagakis P, Polydorou D, Kostakis P, Rigopoulos D. Gregoriou S, et al. Among authors: panagakis p. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e519-e520. doi: 10.1111/jdv.16426. Epub 2020 May 6. J Eur Acad Dermatol Venereol. 2020. PMID: 32259356 No abstract available.
Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology-Rheumatology clinic: a retrospective real-world study.
Klavdianou K, Stavropoulou M, Panagakis P, Papoutsaki M, Panagiotopoulos A, Koutsianas C, Stratigos A, Rigopoulos D, Vassilopoulos D. Klavdianou K, et al. Among authors: panagakis p. Rheumatol Int. 2022 Jun;42(6):1035-1041. doi: 10.1007/s00296-022-05126-z. Epub 2022 Apr 18. Rheumatol Int. 2022. PMID: 35435445
Short-Term Correlation of the Psoriasis Area Severity Index, the Nail Psoriasis Area Severity Index, and the Dermatology Life Quality Index, before and after Treatment, in Patients with Skin and Nail Psoriasis.
Prevezas C, Katoulis AC, Papadavid E, Panagakis P, Rigopoulos D. Prevezas C, et al. Among authors: panagakis p. Skin Appendage Disord. 2019 Nov;5(6):344-349. doi: 10.1159/000499348. Epub 2019 May 21. Skin Appendage Disord. 2019. PMID: 31799260 Free PMC article.
16 results